SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Eden Rahim - Next Edge Capital - SQI Diagnostics

<< Previous

Bullboard Posts

Next >>

Comment by FactFinder1994on Nov 24, 2020 9:04pm

153 Views

Post# 31966959

RE:Eden Rahim - Next Edge Capital - SQI Diagnostics

Apparently I've fallen behind, as Next Edge Capital (Eden Rahim) now has about 2% of SQD float, not 1%. They have obviously been topping up over the last months. This bodes very well for both SQD and MBX holders.

Stay tuned,

Here are Next Edge Capital's top holdings:

Symbol	Shares Held
ICO	6,650,500
AQS	6,450,500
SQD	6,145,000
MBX	2,723,000
XRAY	1,005,500
CGN	436,500
OPS	395,000
TRIL	220,000
IPA	150,000
CPH	145,000
HTL	90,000
TH	70,000
CRDL	45,000
MPH	25,000
DMA	6,350